S HP

No ORCID on file · 1 paper in corpus
review 2022
European journal of clinical pharmacology ·doi:10.1007/s00228-021-03256-0

PurposeMedical management of adenomyosis largely revolves around symptom management, with very few drugs having received regulatory approval for the disease. However, the level of evidence supporting the use of pharmacological interventions…